GB201815694D0 - Prevention and treatment of cancer - Google Patents

Prevention and treatment of cancer

Info

Publication number
GB201815694D0
GB201815694D0 GBGB1815694.3A GB201815694A GB201815694D0 GB 201815694 D0 GB201815694 D0 GB 201815694D0 GB 201815694 A GB201815694 A GB 201815694A GB 201815694 D0 GB201815694 D0 GB 201815694D0
Authority
GB
United Kingdom
Prior art keywords
cancer
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1815694.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Adelaide
UCB Biopharma SRL
Oxford University Innovation Ltd
Original Assignee
University of Adelaide
UCB Biopharma SRL
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Adelaide, UCB Biopharma SRL, Oxford University Innovation Ltd filed Critical University of Adelaide
Priority to GBGB1815694.3A priority Critical patent/GB201815694D0/en
Publication of GB201815694D0 publication Critical patent/GB201815694D0/en
Priority to MX2020013808A priority patent/MX2020013808A/en
Priority to AU2019289176A priority patent/AU2019289176A1/en
Priority to KR1020217001142A priority patent/KR20210028191A/en
Priority to SG11202012312UA priority patent/SG11202012312UA/en
Priority to JP2020570158A priority patent/JP2021528400A/en
Priority to CA3102743A priority patent/CA3102743A1/en
Priority to PCT/GB2019/051699 priority patent/WO2019243801A1/en
Priority to US17/253,660 priority patent/US20210253688A1/en
Priority to EP19734460.9A priority patent/EP3806898A1/en
Priority to BR112020025661-7A priority patent/BR112020025661A2/en
Priority to CN201980041089.7A priority patent/CN112533632A/en
Priority to IL279347A priority patent/IL279347A/en
Priority to CL2020003249A priority patent/CL2020003249A1/en
Priority to CONC2020/0015923A priority patent/CO2020015923A2/en
Ceased legal-status Critical Current

Links

GBGB1815694.3A 2018-06-18 2018-09-26 Prevention and treatment of cancer Ceased GB201815694D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GBGB1815694.3A GB201815694D0 (en) 2018-09-26 2018-09-26 Prevention and treatment of cancer
CN201980041089.7A CN112533632A (en) 2018-06-18 2019-06-18 GREMLIN-1 antagonists for the prevention and treatment of cancer
CA3102743A CA3102743A1 (en) 2018-06-18 2019-06-18 Gremlin-1 antagonist for the prevention and treatment of cancer
US17/253,660 US20210253688A1 (en) 2018-06-18 2019-06-18 Gremlin-1 antagonist for the prevention and treatment of cancer
KR1020217001142A KR20210028191A (en) 2018-06-18 2019-06-18 GREMLIN-1 antagonists for preventing and treating cancer
SG11202012312UA SG11202012312UA (en) 2018-06-18 2019-06-18 Gremlin-1 antagonist for the prevention and treatment of cancer
JP2020570158A JP2021528400A (en) 2018-06-18 2019-06-18 GREMLIN-1 antagonist for the prevention and treatment of cancer
MX2020013808A MX2020013808A (en) 2018-06-18 2019-06-18 Gremlin-1 antagonist for the prevention and treatment of cancer.
PCT/GB2019/051699 WO2019243801A1 (en) 2018-06-18 2019-06-18 Gremlin-1 antagonist for the prevention and treatment of cancer
AU2019289176A AU2019289176A1 (en) 2018-06-18 2019-06-18 Gremlin-1 antagonist for the prevention and treatment of cancer
EP19734460.9A EP3806898A1 (en) 2018-06-18 2019-06-18 Gremlin-1 antagonist for the prevention and treatment of cancer
BR112020025661-7A BR112020025661A2 (en) 2018-06-18 2019-06-18 anti-grem1 antagonist, anticancer agent, methods of treating a cancer and predicting a cancer, composition or kit, methods for detecting cancer, to determine whether a patient with or suspected of having or at risk of developing cancer is or not likely to respond to treatment with a chemotherapeutic agent, and to determine whether a patient with or suspected of having or at risk of developing cancer is likely to respond to treatment with a grem antagonist1
IL279347A IL279347A (en) 2018-06-18 2020-12-10 Gremlin-1 antagonist for the prevention and treatment of cancer
CL2020003249A CL2020003249A1 (en) 2018-06-18 2020-12-15 Gremlin-1 antagonist for the prevention and treatment of cancer
CONC2020/0015923A CO2020015923A2 (en) 2018-06-18 2020-12-17 Gremlin-1 antagonist for the prevention and treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1815694.3A GB201815694D0 (en) 2018-09-26 2018-09-26 Prevention and treatment of cancer

Publications (1)

Publication Number Publication Date
GB201815694D0 true GB201815694D0 (en) 2018-11-07

Family

ID=64024412

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1815694.3A Ceased GB201815694D0 (en) 2018-06-18 2018-09-26 Prevention and treatment of cancer

Country Status (1)

Country Link
GB (1) GB201815694D0 (en)

Similar Documents

Publication Publication Date Title
HK1252873A1 (en) Vaccines for treatment and prevention of cancer
IL268814A (en) Compositions and methods for treatment of cancer
IL279347A (en) Gremlin-1 antagonist for the prevention and treatment of cancer
FI3773689T3 (en) Antigenic peptides for prevention and treatment of cancer
SG11202011117VA (en) Treatment of cancer
EP3749342A4 (en) Bacteriophage for treatment and prevention of bacteria-associated cancers
ZA202000558B (en) Prevention and/or treatment of neurodegenerative disease
IL276905A (en) Treatment and prevention of pre-eclampsia
IL276203A (en) Compositions and methods of treating cancer
IL272147A (en) Methods and compositions for the treatment of cancer
IL267613A (en) Treatment of pancreatic cancer
EP3579840C0 (en) Treatment of cancer and inhibition of metastasis
FI3630112T3 (en) Combination of regorafenib and nivolumab for treating cancer
EP3490971A4 (en) Methods of treating and preventing cancer treatment side effects
IL280262A (en) Compositions and methods for the treatment of cancer
EP3987032A4 (en) Methods and compositions for the treatment of cancer
IL270306A (en) Prevention and treatment of pre-myeloid and myeloid malignancies
GB201815694D0 (en) Prevention and treatment of cancer
GB201809946D0 (en) Prevention and treatment of cancer
GB201815000D0 (en) Treatment of hypothroidism and related conditions
GB201918815D0 (en) Treatment of cancer
IL276121A (en) Treatment and prevention of seed allergies
IL274748A (en) Improved treatment of cancer
GB201816542D0 (en) Treatment and prevention of malaria
GB201820975D0 (en) Methods of cancer treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)